Vaccines, gene-editing-based therapies, and immunotherapies will transform the current lan... 04/02/2025 Healthcare Access to innovation Drug discovery Innovative drugs Personalized medicine Advanced therapies Biotechnology has radically changed the treatment of many types of tumors, evolving from highly aggressive and non... AseBio - BATEA ONCOLOGY S.L.
Vaccines, gene-editing-based therapies, and immunotherapies will transform the current lan... 04/02/2025 BATEA ONCOLOGY S.L. It will also be necessary to develop therapies with fewer side effects, allowing the combination of different treatments... AseBio - BATEA ONCOLOGY S.L.
Integra Therapeutics part of Spanish Government presentation of ‘HispanIA 2040’ as an AI f... 28/01/2025 Healthcare Access to innovation Personalized medicine Gene editing HispanIA 2040 is a strategic study promoted by the Spanish National Office of Foresight and Strategy, compiled by 12... Partners - Integra Therapeutics S.L.
GENESIS Biomed advised Corify Care on the closing of its latest €6M investment round last ... 24/01/2025 Healthcare Access to innovation Financing GENESIS Biomed directly invested €50,000 in Corify Care in this round as a sign of commitment to the project. This is... Partners - GENESIS Biomed
The EIC identifies biotechnology for its potential to contribute to European competitivene... 22/01/2025 Healthcare Access to innovation Agrifood Industrial biotechnology This report aims to provide an overview of the most promising emerging developments to serve as a reference for Europe's... AseBio
Francisco Fernández-Avilés: "The development of imaging techniques in cardiology helps sig... 16/01/2025 Healthcare Access to innovation Interview Francisco Fernández-Avilés – Professor of Cardiovascular Medicine at the UCM and Co-Founder of Corify Care. Partners - GENESIS Biomed
January 30: A key date for clinical research in europe: the transition to CTIS will mark a... 17/01/2025 Healthcare Access to innovation Industrial biotechnology EU projects We interviewed Lidya Domínguez, Director of Clinical Research at Sermes CRO, experts in European clinical trial... AseBio - Sermes CRO
New Approach to Glycovaccines 18/12/2024 Healthcare Access to innovation Innovative drugs IQS researchers are designing a new generation of glyconanoparticles functionalized with α-mannose to produce new, more... Partners - IQS
Alira Health Unveils 2024 Report on Antibody-Drug Conjugates Market 18/12/2024 Healthcare Access to innovation Drug discovery Analysis projects 21% annual growth, with global sales expected to reach $39 billion by 2030. Partners
8TH ANNUAL NEUROSCIENCE INNOVATION FORUM FOR BUSINESS DEVELOPMENT, LICENSING & INVESTMENT San Francisco United States Del 12/01/2025 to 12/01/2025 Healthcare Access to innovation International
